Contact Information
Email
l****@emergexvaccines.com
Unlock
Company Information
Company
EMERGEX VACCINES HOLDING LIMITED
Technologies
Outlook
Microsoft Office 365
Google Font API
Google Maps
WordPress.org
Apache
Typekit
Mobile Friendly
Keywords
biotechnology research
t cell-priming
vaccine
immunotherapy
synthetic vaccines
infectious diseases
cellular immune responses
long-lasting immunity
nanotechnology
microneedle delivery
patch-based therapeutics
assembly of t cells
vaccine development
dengue fever
betacoronavirus
universal influenza
clinical trials
antigen presenting cells
public health
immunoproteomics
multi-omic technologies
mhc class i
pathogen-derived peptides
viral peptides
intradermal administration
gmp manufacturing
immunization compliance
pathogen response
chikungunya virus
t cell immunity
safety profile
cold chain requirements
cd8+ t cells
vaccine technology
immune system activation
synthetic immunity
dendritic cell activation
biosecurity
emergency vaccine development
medical countermeasures
clinical research
therapeutic vaccines
global health
prevention strategies
healthcare innovation
long-term protection
viral infections
pharmaceutical partnering
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans